Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 11-17 Year-Old Subjects

NCT00464815 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1025

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Meningococcal

Interventions

BIOLOGICAL: Meningococcal vaccine GSK134612
BIOLOGICAL: Mencevax™ ACWY

Sponsor

GlaxoSmithKline